Master Alliance Provisions Guide (MAPGuide)

MPP License Agreement with BMS & Aurobindo Pharma Ltd.

  • IP ownership & licensing | Use of background IP

§4 Commercialization:

The sublicensee will be responsible, at its own expense, for the conduct of all activities relating to the Commercialization of the Licensed Products in the Territory.

Each Licensed Product Commercialized by the Sublicensee under this Sublicense Agreement will be marked (to the extent not prohibited by law), with a notice that such Licensed Product is sold under a license from BMS and MPP.

The Sublicensee will use all reasonable efforts to provide an adequate supply of the Licensed Products (in all formulations and strengths) to meet the therapeutic needs in the Territory and will provide a strong supply network to support the distribution of the Licensed Products in the Territory. In recognition of the humanitarian objectives of this Sublicense Agreement, the Sublicensee also will use all reasonable efforts to promote the affordable access to the Licensed Products in the Territory.